RAB13

Across TCGA pan-cancer cohorts, RAB13 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RAB13 data layer compared with 4 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RAB13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAB13 expression acts as an unfavorable survival marker, although some lineages such as DLBC and SARC show a favorable association.

ACC, KIRP, and LGG are the cancer types where RAB13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.201	0.731	<.001	89	view →
KIRP	DFS	Tertile	II,III,IV	0.439	0.823	<.001	70	view →
LGG	DFS	Median	All	0.670	0.800	<.001	49	view →
LIHC	OS	Median	All	0.606	0.765	<.001	47	view →
LUAD	OS	Quartile	All	0.751	0.908	<.001	39	view →
UVM	OS	Median	III,IV	0.327	0.905	<.001	35	view →
COAD	DFS	Quartile	All	0.719	0.888	.007	27	view →
DLBC	DFS	Median	III,IV	0.984	0.169	.001	21	view →
THYM	OS	Median	All	0.745	0.966	.001	20	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	20	view →
SCLC	DFS	Median	III,IV	0.338	0.968	.024	18	view →
READ	DFS	Median	III,IV	0.341	0.810	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RAB13–ACC (DFS)

Open the ACC breakdown →